Genentech

Genentech, Inc. is a biotechnology corporation based in South San Francisco, California, and operates as an independent subsidiary of the Roche Group. Founded in April 1976, it is recognized as the world's first biotechnology company. Genentech focuses on the discovery, development, manufacturing, and commercialization of innovative biopharmaceutical medicines, employing around 12,300 people globally. The company specializes in various therapeutic areas, including oncology, immunology, neuroscience, ophthalmology, infectious disease, metabolism, and tissue growth and repair. Genentech is known for its patient-first philosophy and offers patient support services such as co-pay assistance and health insurance navigation. It has achieved significant breakthroughs in medicine, including the first targeted antibody for cancer and the first treatment for primary progressive multiple sclerosis. Its product portfolio features monoclonal antibodies, small molecules, and biologic medicines aimed at addressing serious health conditions.